INFUSYSTEM HOLDINGS, INC Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INFUSYSTEM HOLDINGS, INC stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 61.47K shares, a 16.06% increase from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC stock issued during period, shares, employee stock purchase plans for fiscal 2024 was 52.97K shares, a 26.05% decline from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC stock issued during period, shares, employee stock purchase plans for fiscal 2023 was 71.62K shares, a 18.05% increase from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC stock issued during period, shares, employee stock purchase plans for fiscal 2022 was 60.67K shares, a 91.86% increase from fiscal 2021.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2025-12-31 | 61.47K shares 10-K · filed 2026-02-27 | |
| 2024-12-31 | 52.97K shares 10-K · filed 2026-02-27 | |
| 2023-12-31 | 71.62K shares 10-K · filed 2025-03-11 | |
| 2022-12-31 | 60.67K shares 10-K · filed 2024-04-10 | |
| 2021-12-31 | 31.62K shares 10-K · filed 2024-04-10 | |
| 2020-12-31 | 30.01K shares 10-K · filed 2023-03-16 | |
| 2019-12-31 | 33.74K shares 10-K · filed 2022-03-15 | |
| 2018-12-31 | 43.43K shares 10-K · filed 2020-03-30 | |
| 2017-12-31 | 68.96K shares 10-K · filed 2019-03-22 | |
| 2016-12-31 | 88.11K shares 10-K · filed 2018-03-19 | |
| 2015-12-31 | 98.07K shares 10-K · filed 2017-03-22 | |
| 2014-12-31 | 0.00 shares 10-K/A · filed 2016-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |